Therapeutic effects of the dipeptidyl peptidase-IV inhibitor, sitagliptin, on non-alcoholic steatohepatitis in FLS-ob/ob male mice

Author：              

Publisher： Spandidos Publications

E-ISSN： 1791-3004|12|5|6895-6902

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.12, Iss.5, 2015-01, pp. : 6895-6902

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The dipeptidyl peptidase-4 inhibitor sitagliptin suppresses mouse colon tumorigenesis in type 2 diabetic mice

By                      

Oncology Reports, Vol. 35, Iss. 2, 2016-01 ,pp. : 676-682

Spandidos Publications

Access to resources Recommend Favorite

Increased hepatic expression of dipeptidyl peptidase-4 in non-alcoholic fatty liver disease and its association with insulin resistance and glucose metabolism

By                    

Molecular Medicine Reports, Vol. 5, Iss. 3, 2012-01 ,pp. : 729-733

Spandidos Publications

Access to resources Recommend Favorite

Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells

By Pethiyagoda C.L.   Welch D.R.   Fleming T.P.  

Clinical and Experimental Metastasis, Vol. 18, Iss. 5, 2000-09 ,pp. : 391-400

Springer Publishing Company

Access to resources Recommend Favorite

Nifedipine prevents hepatic fibrosis in a non-alcoholic steatohepatitis model induced by an L-methionine-and choline-deficient diet

By                          

Molecular Medicine Reports, Vol. 5, Iss. 1, 2012-01 ,pp. : 37-40

Spandidos Publications

Access to resources Recommend Favorite

Dipeptidyl peptidase III in malignant and non-malignant gynaecological tissue

By Simaga S.   Babic D.   Osmak M.   Ilic-Forko J.   Vitale L.   Milicic D.   Abramic M.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 399-405

Elsevier

Access to resources Recommend Favorite